GOSSAMER BIO
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
GOSSAMER BIO
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.gossamerbio.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
600 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
NextCure
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-07-17 | Adhaere Pharmaceuticals | Adhaere Pharmaceuticals acquired by Gossamer Bio | N/A |
Investors List
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Gossamer Bio
Boxer Capital
Boxer Capital investment in Post-IPO Equity - Gossamer Bio
Monashee Investment Management
Monashee Investment Management investment in Post-IPO Equity - Gossamer Bio
Invus
Invus investment in Post-IPO Equity - Gossamer Bio
Weiss Asset Management
Weiss Asset Management investment in Post-IPO Equity - Gossamer Bio
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Gossamer Bio
Madison Avenue Partners
Madison Avenue Partners investment in Post-IPO Equity - Gossamer Bio
Rock Springs Capital
Rock Springs Capital investment in Post-IPO Equity - Gossamer Bio
MidCap Financial
MidCap Financial investment in Post-IPO Debt - Gossamer Bio
Bay City Capital
Bay City Capital investment in Series B - Gossamer Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-21 | Gossamer Bio Announces Appointment of Bryan Giraudo as Chief Operating Officer, in addition to Chief Financial Officer Role |
Official Site Inspections
http://www.gossamerbio.com Semrush global rank: 1.32 M Semrush visits lastest month: 22.23 K
- Host name: 104.26.5.137
- IP address: 104.26.5.137
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Gossamer Bio"
About Us - Gossamer Bio
The name Gossamer Bio was derived from the meaning behind the Gossamer Thread, which is the invisible and fragile connection that binds all relationships …See details»
Management - Gossamer Bio
The name Gossamer Bio depicts the symbolism behind the gossamer thread, the fragile connection that binds all relationships in life. In our context, this is intended to highlight the …See details»
Gossamer Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address …See details»
Gossamer Bio, Inc. (GOSS) Company Profile & Facts - Yahoo Finance
See the company profile for Gossamer Bio, Inc. (GOSS) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Gossamer Bio - Overview, News & Similar companies - ZoomInfo
May 20, 2024 Gossamer Bio contact info: Phone number: (858) 684-1300 Website: www.gossamerbio.com What does Gossamer Bio do? Gossamer Bio is a clinical-stage …See details»
Gossamer Bio Inc Company Profile - GlobalData
Website www.gossamerbio.com Telephone 1 858 9220718. No of Employees 185. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange GOSS (NASD) EPS XYZ. Net …See details»
Gossamer Bio Announces First Quarter 2023 Financial …
May 9, 2023 Gossamer Bio Statement of Operations. Condensed Consolidated Statement of Operations (in thousands, except share and per share amounts) (unaudited)See details»
Gossamer Bio Announces Publication of TORREY Phase 2 Results …
May 3, 2024 SAN DIEGO--(BUSINESS WIRE)--May 3, 2024-- Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and …See details»
about us. - Gossamer Bio
We are a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension. Our goal …See details»
Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., …
Nov 29, 2023 SAN DIEGO--(BUSINESS WIRE)--Nov. 29, 2023-- Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and …See details»
Gossamer Bio to Host Webcast Announcing its Next Clinical …
The live audio webcast may be accessed through the “Events / Presentations” page in the “Investors” section of the Company's website at www.gossamerbio.com. Alternatively, the …See details»
Patients - Gossamer Bio
Gossamer Bio was named in symbolism of the Gossamer thread, the invisible and fragile connection that binds all relationships in life. Gossamer’s name was chosen to highlight the …See details»
Gossamer Bio, Inc. (GOSS) - Yahoo Finance Canada
Find the latest Gossamer Bio, Inc. (GOSS) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Gossamer Bio Announces Early Encouraging Safety and Biomarker …
Mar 27, 2020 SAN DIEGO--(BUSINESS WIRE)--May 29, 2020-- Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, …See details»
Gossamer Bio Announces Addition of Two CNS-Penetrant BTK …
Oct 11, 2021 The live audio webcast may be accessed through the “Events / Presentations” page in the “Investors” section of the Company's website at www.gossamerbio.com. …See details»
Gossamer Bio Announces $120 Million Private Placement Financing
Jul 13, 2022 Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapSee details»
Patients Overview - Gossamer Bio
Gossamer Bio was named in symbolism of the Gossamer thread, the invisible and fragile connection that binds all relationships in life. Gossamer’s name was chosen to highlight the …See details»
Investor FAQs - Gossamer Bio
The Investor Relations website contains information about Gossamer Bio's business for stockholders, potential investors, and financial analysts.See details»
Gossamer Bio - Craft
Aug 12, 2024 Gossamer Bio has 3 employees across 2 locations. See insights on Gossamer Bio including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»